Comments
Loading...

Johnson & Johnson Analyst Ratings

JNJNYSE
Logo brought to you by Benzinga Data
$152.49
At close: May 20 EDT
$152.69
0.200.13%
Pre-Market: 9:00 AM EDT
The dividend Ex-Date is in 7 days
Consensus Rating1
Buy
Highest Price Target1
$215.00
Lowest Price Target1
$150.00
Consensus Price Target1
$170.00

Johnson & Johnson Analyst Ratings and Price Targets | NYSE:JNJ | Benzinga

Johnson & Johnson has a consensus price target of $170 based on the ratings of 19 analysts. The high is $215 issued by Cantor Fitzgerald on October 16, 2024. The low is $150 issued by Daiwa Capital on July 23, 2024. The 3 most-recent analyst ratings were released by Leerink Partners, Barclays, and Raymond James on May 13, 2025, April 17, 2025, and April 16, 2025, respectively. With an average price target of $160.67 between Leerink Partners, Barclays, and Raymond James, there's an implied 5.22% upside for Johnson & Johnson from these most-recent analyst ratings.

Analyst Trends and Forecast
1
1
Feb
3
Mar
6
5
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Leerink Partners
Barclays
Raymond James
Morgan Stanley
RBC Capital

1calculated from analyst ratings

Analyst Ratings for Johnson & Johnson

Buy NowGet Alert
05/13/2025Buy Now0.2%Leerink Partners
David Risinger71%
$169 → $153DowngradeOutperform → Market PerformGet Alert
04/17/2025Buy Now8.06%Barclays
Matt Miksic67%
$166 → $165MaintainsEqual-WeightGet Alert
04/16/2025Buy Now7.41%Raymond James
Jayson Bedford68%
$162 → $164MaintainsOutperformGet Alert
04/16/2025Buy Now10.68%Morgan Stanley
Terence Flynn63%
$164 → $169MaintainsEqual-WeightGet Alert
04/16/2025Buy Now18.54%RBC Capital
Shagun Singh57%
$181 → $181ReiteratesOutperform → OutperformGet Alert
04/14/2025Buy Now6.1%Raymond James
Jayson Bedford68%
$165 → $162MaintainsOutperformGet Alert
04/10/2025Buy Now4.13%B of A Securities
Tim Anderson57%
$171 → $159MaintainsNeutralGet Alert
04/09/2025Buy Now7.41%Morgan Stanley
Terence Flynn63%
$163 → $164MaintainsEqual-WeightGet Alert
04/09/2025Buy Now12.65%Goldman Sachs
Asad Haider 36%
$157 → $172UpgradeNeutral → BuyGet Alert
04/03/2025Buy Now18.54%RBC Capital
Shagun Singh57%
$181 → $181ReiteratesOutperform → OutperformGet Alert
04/02/2025Buy Now18.54%RBC Capital
Shagun Singh57%
$181 → $181ReiteratesOutperform → OutperformGet Alert
04/02/2025Buy NowGuggenheim
Vamil Divan72%
ReiteratesNeutral → NeutralGet Alert
03/12/2025Buy NowGuggenheim
Vamil Divan72%
ReiteratesNeutral → NeutralGet Alert
03/10/2025Buy NowGuggenheim
Vamil Divan72%
ReiteratesNeutral → NeutralGet Alert
03/05/2025Buy Now11.99%B of A Securities
Tim Anderson57%
$159 → $171MaintainsNeutralGet Alert
02/19/2025Buy Now18.54%RBC Capital
Shagun Singh57%
$181 → $181ReiteratesOutperform → OutperformGet Alert
02/03/2025Buy Now8.72%Guggenheim
Vamil Divan72%
$162 → $166MaintainsNeutralGet Alert
01/28/2025Buy Now8.72%Barclays
Matt Miksic67%
$159 → $166MaintainsEqual-WeightGet Alert
01/23/2025Buy Now18.54%RBC Capital
Shagun Singh57%
$181 → $181ReiteratesOutperform → OutperformGet Alert
01/23/2025Buy Now6.75%Morgan Stanley
Terence Flynn63%
$175 → $163MaintainsEqual-WeightGet Alert
01/23/2025Buy Now1.51%Stifel
Rick Wise74%
$170 → $155MaintainsHoldGet Alert
01/23/2025Buy Now10.68%Leerink Partners
David Risinger71%
$182 → $169MaintainsOutperformGet Alert
01/23/2025Buy Now-0.45%Wells Fargo
Larry Biegelsen67%
$166 → $152MaintainsEqual-WeightGet Alert
01/23/2025Buy Now8.06%Raymond James
Jayson Bedford68%
$170 → $165MaintainsOutperformGet Alert
01/23/2025Buy Now4.13%B of A Securities
Tim Anderson57%
$160 → $159MaintainsNeutralGet Alert
01/17/2025Buy Now4.79%B of A Securities
Tim Anderson57%
$166 → $160MaintainsNeutralGet Alert
12/11/2024Buy Now14.61%Citigroup
Joanne Wuensch75%
$185 → $175MaintainsBuyGet Alert
12/10/2024Buy Now8.72%B of A Securities
Tim Anderson57%
→ $166Reinstates → NeutralGet Alert
11/15/2024Buy Now24.44%Wolfe Research
Alexandria Hammond37%
→ $190Initiates → OutperformGet Alert
11/06/2024Buy Now6.1%Guggenheim
Vamil Divan72%
$156 → $162MaintainsNeutralGet Alert
10/16/2024Buy Now21.16%Citigroup
Joanne Wuensch75%
$180 → $185MaintainsBuyGet Alert
10/16/2024Buy Now8.72%Wells Fargo
Larry Biegelsen67%
$163 → $166MaintainsEqual-WeightGet Alert
10/16/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
10/16/2024Buy Now18.54%RBC Capital
Shagun Singh57%
$178 → $181MaintainsOutperformGet Alert
10/16/2024Buy Now14.61%Morgan Stanley
Terence Flynn63%
$169 → $175MaintainsEqual-WeightGet Alert
10/10/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
10/08/2024Buy Now16.58%RBC Capital
Shagun Singh57%
$175 → $178MaintainsOutperformGet Alert
09/30/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
09/23/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
09/20/2024Buy Now14.61%RBC Capital
Shagun Singh57%
$175 → $175ReiteratesOutperform → OutperformGet Alert
09/19/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
09/16/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
09/09/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
09/03/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
08/05/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
07/30/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
07/30/2024Buy Now14.61%RBC Capital
Shagun Singh57%
$175 → $175ReiteratesOutperform → OutperformGet Alert
07/23/2024Buy Now-1.76%Daiwa Capital
Narumi Nakagiri22%
$160 → $150DowngradeOutperform → NeutralGet Alert
07/19/2024Buy Now1.51%Goldman Sachs
Chris Shibutani54%
$160 → $155MaintainsNeutralGet Alert
07/18/2024Buy Now14.61%RBC Capital
Shagun Singh57%
$175 → $175ReiteratesOutperform → OutperformGet Alert
07/18/2024Buy Now21.16%TD Cowen
Joshua Jennings55%
$195 → $185MaintainsBuyGet Alert
07/18/2024Buy Now10.68%Morgan Stanley
Terence Flynn63%
$167 → $169MaintainsEqual-WeightGet Alert
07/01/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
06/25/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
06/20/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
06/17/2024Buy Now14.61%RBC Capital
Shagun Singh57%
$175 → $175ReiteratesOutperform → OutperformGet Alert
06/04/2024Buy Now14.61%RBC Capital
Shagun Singh57%
$175 → $175ReiteratesOutperform → OutperformGet Alert
05/22/2024Buy Now14.61%RBC Capital
Shagun Singh57%
$175 → $175ReiteratesOutperform → OutperformGet Alert
05/16/2024Buy Now14.61%RBC Capital
Shagun Singh57%
$175 → $175ReiteratesOutperform → OutperformGet Alert
05/06/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
04/18/2024Buy Now11.34%HSBC
Morten Herholdt39%
$169 → $170UpgradeHold → BuyGet Alert
04/17/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
04/17/2024Buy Now9.37%Morgan Stanley
Terence Flynn63%
$168 → $167MaintainsEqual-WeightGet Alert
04/17/2024Buy Now14.61%RBC Capital
Shagun Singh57%
$181 → $175MaintainsOutperformGet Alert
04/17/2024Buy Now11.34%B of A Securities
Geoff Meacham60%
$180 → $170MaintainsNeutralGet Alert
04/15/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
03/13/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
02/28/2024Buy Now18.54%RBC Capital
Shagun Singh57%
$181 → $181ReiteratesOutperform → OutperformGet Alert
02/20/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
02/06/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
01/24/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
01/24/2024Buy Now18.54%RBC Capital
Shagun Singh57%
$181 → $181ReiteratesOutperform → OutperformGet Alert
01/24/2024Buy Now10.68%Morgan Stanley
Terence Flynn63%
$170 → $169MaintainsEqual-WeightGet Alert
01/23/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
01/09/2024Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
01/03/2024Buy Now14.61%Raymond James
Jayson Bedford68%
$172 → $175MaintainsOutperformGet Alert
12/13/2023Buy Now6.75%Wells Fargo
Larry Biegelsen67%
$170 → $163DowngradeOverweight → Equal-WeightGet Alert
12/06/2023Buy Now18.54%RBC Capital
Shagun Singh57%
$178 → $181MaintainsOutperformGet Alert
12/01/2023Buy Now16.58%RBC Capital
Shagun Singh57%
$178 → $178ReiteratesOutperform → OutperformGet Alert
12/01/2023Buy Now17.89%UBS
Danielle Antalffy60%
→ $180UpgradeNeutral → BuyGet Alert
11/20/2023Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
11/17/2023Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
10/23/2023Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
10/18/2023Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
10/18/2023Buy Now12.65%Raymond James
Jayson Bedford68%
$179 → $172MaintainsOutperformGet Alert
10/18/2023Buy Now11.99%Morgan Stanley
Terence Flynn63%
$174 → $171MaintainsEqual-WeightGet Alert
10/12/2023Buy Now6.1%Barclays
Matt Miksic67%
$158 → $162MaintainsEqual-WeightGet Alert
10/11/2023Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
$215 → $215ReiteratesOverweight → OverweightGet Alert
10/11/2023Buy Now13.96%Morgan Stanley
Terence Flynn63%
$172 → $174MaintainsEqual-WeightGet Alert
10/09/2023Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
10/05/2023Buy Now16.58%RBC Capital
Shagun Singh57%
→ $178Initiates → OutperformGet Alert
10/02/2023Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
09/18/2023Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
09/08/2023Buy Now3.48%Barclays
Matt Miksic67%
$175 → $158MaintainsEqual-WeightGet Alert
09/06/2023Buy Now14.61%HSBC
Morten Herholdt39%
→ $175Initiates → HoldGet Alert
09/05/2023Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
09/05/2023Buy Now17.23%Raymond James
Jayson Bedford68%
$184 → $179MaintainsOutperformGet Alert
08/31/2023Buy Now21.82%Wells Fargo
Larry Biegelsen67%
$195 → $186MaintainsOverweightGet Alert
08/31/2023Buy Now40.81%Cantor Fitzgerald
Louise Chen52%
→ $215ReiteratesOverweight → OverweightGet Alert
08/31/2023Buy Now12.65%Morgan Stanley
Terence Flynn63%
$187 → $172MaintainsEqual-WeightGet Alert

FAQ

Q

What is the target price for Johnson & Johnson (JNJ) stock?

A

The latest price target for Johnson & Johnson (NYSE:JNJ) was reported by Leerink Partners on May 13, 2025. The analyst firm set a price target for $153.00 expecting JNJ to rise to within 12 months (a possible 0.20% upside). 58 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Johnson & Johnson (JNJ)?

A

The latest analyst rating for Johnson & Johnson (NYSE:JNJ) was provided by Leerink Partners, and Johnson & Johnson downgraded their market perform rating.

Q

When was the last upgrade for Johnson & Johnson (JNJ)?

A

The last upgrade for Johnson & Johnson happened on April 9, 2025 when Goldman Sachs raised their price target to $172. Goldman Sachs previously had a neutral for Johnson & Johnson.

Q

When was the last downgrade for Johnson & Johnson (JNJ)?

A

The last downgrade for Johnson & Johnson happened on May 13, 2025 when Leerink Partners changed their price target from $169 to $153 for Johnson & Johnson.

Q

When is the next analyst rating going to be posted or updated for Johnson & Johnson (JNJ)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Johnson & Johnson, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Johnson & Johnson was filed on May 13, 2025 so you should expect the next rating to be made available sometime around May 13, 2026.

Q

Is the Analyst Rating Johnson & Johnson (JNJ) correct?

A

While ratings are subjective and will change, the latest Johnson & Johnson (JNJ) rating was a downgraded with a price target of $169.00 to $153.00. The current price Johnson & Johnson (JNJ) is trading at is $152.69, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch